Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health management to break up the healthcare giant — denies it is “pushing ...

However, Glenview Capital said in a statement that's not behind the potential breakup plan. The hedge fund met with CVS officials on Monday, and reports about the strategic review quickly followed.

The slated meeting, between CVS and hedge fund Glenview Capital Management, comes amid signs investors are turning restless with a company that remains among the best-recognized in the healthcare ...

Glenview said its shares in CVS had generated a 25% return since it made purchases in May 2024. Its role as a major investor gave it the scale needed to have key conversations with leaders and ...

Since our purchases in May 2024, CVS shares have generated a total return of 25% reflecting initial progress in the long-term cultural and ... Glenview Capital Issues Statement on CVS Health. PR ...

The slated meeting, between CVS and hedge fund Glenview Capital Management, comes amid signs investors are turning restless with a company that remains among the best-recognized in the healthcare ...

May 6 (Reuters) - Activist investor Glenview Capital said on Tuesday it had reduced its holdings in CVS Health , opens new tab following the insurer's "healthy" first-quarter results.

Glenview Capital has amassed a sizable stake in CVS Health and plans to meet with the company's top executives to lay out its plan for value creation, according to people familiar with the matter.

Glenview's founder Larry Robbins has built a large stake in the company, the WSJ reported. CVS amounts to roughly $700 million of Robbins' $2.5 billion hedge fund, it said, adding that Glenview ...

Glenview Capital Management has denied media reports that it is "pushing for a break-up" of CVS Health. The Wall Street Journal on Monday published an "exclusive" story headlined, "Glenview ...

Glenview Capital Issues Statement on CVS Health. PR Newswire. NEW YORK, May 6, 2025. NEW YORK, May 6, 2025 /PRNewswire/ -- One year ago, we established a concentrated position in shares of CVS ...

NEW YORK, Oct. 18, 2024 /PRNewswire/ -- Earlier, Glenview and CVS executed a Non-Disclosure Agreement to facilitate the good faith exchange of information and perspectives and discussions ...